Skip to main content
Equibles
WELL logo

WELL · Welltower Inc.

Track WELL — free

Use WELL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about WELL

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$235.72 +0.28 (+0.12%) At close · Aug 19
Market Cap
$166.20B
Shares
705.91M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$235.44 Open$235.74 Day$235.00–238.85 52W close$162.41–252.07 Avg vol 30d3.0M Short int17.7M · 2.5% float · 5.9d Short vol55% Last earningsJul 28, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 27, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 28, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very Low
      Market backdrop VIX 14.9 · calm Equity put/call 0.64
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +13%
      above
      Price vs 50-day avg +2%
      above
      RSI (14) 51
      neutral
      MACD trend Negative
      52-week position 81%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return −4%
      trailing
      6-month return +13%
      trailing
      YTD return +27%
      this year
      Relative strength +2%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $230 › 200d $208 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +206 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.51% of float · ▼ -7.2% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,588 holders — near 3-yr high, broad support
      Squeeze score 58
      elevated · 0–100
      Fundamentals
      Weak
      Revenue growth +36%
      Y/Y
      EPS growth −11%
      Y/Y
      Valuation P/E 117.1
      rich
      Buyback $3.0B
      remaining
      Balance sheet $14.2B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 23%
      annualized · 1-yr
      Max drawdown −13%
      past year
      ATR 2.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 27, 2026
      full year 2026
      Net income attributable to common stockholders $3.11 – $3.19
      Normalized FFO attributable to common stockholders $6.36 – $6.44
      Same Store NOI growth (blended) 13.75% – 16%
      Seniors Housing Operating SSNOI growth 18.5% – 21.5%
      Seniors Housing Triple-net SSNOI growth 3.5% – 4.5%
      Outpatient Medical SSNOI growth 2% – 3%
      Stock-based compensation expense $60M
      Long-Term/Post-Acute Care SSNOI growth 2% – 3%
      General and administrative expenses $265M – $270M
      next twelve months
      Pro rata disposition proceeds $1.1B
      Prior guidance period ended · from the 8-K filed Oct 27, 2025
      Normalized FFO attributable to common stockholders · full year 2025 $5.24 – $5.30
      Same Store NOI growth (blended) · full year 2025 13.2% – 14.5%
      Seniors Housing Operating SSNOI growth · full year 2025 20.5% – 22%
      Seniors Housing Triple-net SSNOI growth · full year 2025 3.5% – 4.5%
      Outpatient Medical SSNOI growth · full year 2025 2% – 3%
      Long-Term/Post-Acute Care SSNOI growth · full year 2025 2% – 3%
      General and administrative expenses · full year 2025 $243M – $249M
      Stock-based compensation expense · full year 2025 $52M
      Development funding · full year 2025 $80M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +13% Bullish
      Price vs 50-day avg
      +2% Bullish
      RSI (14)
      51 Neutral
      MACD trend
      Negative Bearish
      52-week position
      81% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $230 › 200d $208 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +206 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.51% of float · ▼ -7.2% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,588 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $162 Now $235 · 81% Range high $252
      vs 200-day avg +13% vs 50-day avg +2%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP 1.35B Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP EBITDA 1.32B
      +17.97M Loss (income) from unconsolidated entities
      +15.5M Stock-based compensation
      +1.98M Loss (gain) on extinguishment of debt, net
      -98.54M Loss (gain) on real estate dispositions and acquisitions of controlling interests, net
      +25.77M Impairment of assets
      +2.18M Provision for loan losses, net
      +56.93M Other expenses
      +5.04M Casualty losses, net of recoveries
      = Adjusted EBITDA 1.35B
      Adjusted EBITDA annualized non-GAAP 5.39B Three Months Ended June 30, 2026 —
      available liquidity non-GAAP $9.5B second quarter —
      Average age (years) 11 2Q26 —
      Average building size (square feet) 75,866 2Q26 —
      Average remaining lease term (years) 11.8 2Q26 —
      Average units in service non-GAAP 112,241 2Q26 —
      Common shares outstanding 718.9M June 30, 2026 —
      Consolidated enterprise value non-GAAP 180.54B June 30, 2026 —
      Health system affiliated properties as % of NOI 99.7% 2Q26 —
      Health system affiliated tenants as % of rental income 93.5% 2Q26 —
      Investment grade tenants as % of rental income 94.7% 2Q26 —
      Long-Term/Post-Acute Care SSNOI non-GAAP 106.43M Three Months Ended June 30, 2026 —
      Long-Term/Post-Acute Care SSNOI growth non-GAAP 2.9% Three Months Ended June 30, 2026 —
      Long-Term/Post-Acute Care stable portfolio occupancy 81.5% March 31, 2026 —
      NAREIT FFO attributable to common stockholders 1.15B Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss) attributable to common stockholders 445M
      +737.76M Depreciation and amortization
      -72.76M Impairments and losses (gains) on real estate dispositions and acquisitions of controlling interests, net
      +10.64M Noncontrolling interests
      +33.01M Unconsolidated entities
      = NAREIT FFO attributable to common stockholders 1.15B
      NAREIT FFO per diluted share $1.56 Three Months Ended June 30, 2026 —
      Net debt non-GAAP 16.12B Three Months Ended June 30, 2026 —
      Normalized FFO attributable to common stockholders non-GAAP 1.18B Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP NAREIT FFO attributable to common stockholders 1.15B
      +26.45M Normalizing items, net
      = Normalized FFO attributable to common stockholders 1.18B
      Normalized FFO payout ratio non-GAAP 46% Three Months Ended June 30, 2026 —
      Normalized FFO per diluted share non-GAAP $1.6 Three Months Ended June 30, 2026 —
      Occupancy 97% 2Q26 —
      Outpatient Medical SSNOI non-GAAP 26.95M Three Months Ended June 30, 2026 —
      Outpatient Medical SSNOI growth non-GAAP 2.4% Three Months Ended June 30, 2026 —
      Outpatient Medical stable portfolio occupancy 97% June 30, 2026 —
      Properties 121 2Q26 —
      Retention (trailing twelve months) 92.8% 2Q26 —
      RevPOR/month in USD non-GAAP $6,285 2Q26 —
      Same Store NOI (SSNOI) non-GAAP 800.5M Three Months Ended June 30, 2026 —
      Same Store NOI (SSNOI) growth non-GAAP 15.5% Three Months Ended June 30, 2026 —
      Seniors Housing Operating SSNOI non-GAAP 584.77M Three Months Ended June 30, 2026 —
      Seniors Housing Operating SSNOI growth non-GAAP 20.5% Three Months Ended June 30, 2026 —
      Seniors Housing Operating stable portfolio occupancy 88.8% June 30, 2026 —
      Seniors Housing Triple-net SSNOI non-GAAP 82.35M Three Months Ended June 30, 2026 —
      Seniors Housing Triple-net SSNOI growth non-GAAP 5.2% Three Months Ended June 30, 2026 —
      Seniors Housing Triple-net stable portfolio occupancy 84.7% March 31, 2026 —
      SHO pro rata SSNOI non-GAAP $584.77M 2Q26 —
      SHO SS RevPOR non-GAAP $6,059 Three Months Ended June 30, 2026 —
      SHO SSNOI/unit non-GAAP $19,203 2Q26 —
      Square feet 4,754,231 2Q26 —
      SS RevPOR YOY growth non-GAAP 5.2% Three Months Ended June 30, 2026 —
      Total acquisitions and loan funding 138 Second Quarter 2026 —
      Total occupancy 87.6% 2Q26 —
      Total properties (portfolio) 2,950 June 30, 2026 —
      Trailing four quarters' SSNOI non-GAAP $2.16B 2Q26 —
      Units 172,155 2Q26 —
      Year over year NOI growth rate 20.5% 2Q26 —
      available cash and restricted cash 4.8B As of March 31, 2026 —
      Net Debt to Adjusted EBITDA non-GAAP 2.73 As of March 31, 2026 —
      normalized funds from operations attributable to common stockholders (per diluted share) non-GAAP $1.47 first quarter —
      pro rata dispositions and loan repayments 2.8B first quarter —
      pro rata gross investments 3.3B first quarter —
      SHO portfolio organic same store revenue growth 9.5% first quarter —
      SHO portfolio SSNOI 22.1% first quarter —
      Annual normalized FFO attributable to common stockholders per diluted share non-GAAP $5.29 full year 2025 —
      Barchester acquisition price £5.2B fourth quarter —
      Barchester communities managed in RIDEA structure 111 fourth quarter —
      Barchester communities subject to long-term triple-net lease 150 fourth quarter —
      Barchester ongoing developments 21 fourth quarter —
      HC-One acquisition equity purchase price £1.2B fourth quarter —
      HC-One existing loan repaid £660M fourth quarter —
      Loan repayment proceeds $1.4B the fourth quarter —
      OM Portfolio pro rata proceeds from sale $5.2B the fourth quarter —
      OM Portfolio properties sold 241 the fourth quarter —
      OM Portfolio size 18M as of December 31, 2025 —
      OM Portfolio total transaction value $7.2B as of December 31, 2025 —
      Pro rata dispositions and loan payoffs completed $7.5B the fourth quarter —
      Pro rata gross investments closed or under contract subsequent to year end $5.7B subsequent to year end —
      Pro rata gross investments completed $13.9B the fourth quarter —
      Pro rata net investments completed $11B full year 2025 —
      Pro rata property dispositions $6.1B the fourth quarter —
      Reported quarterly normalized funds from operations attributable to common stockholders of $1.45 non-GAAP $1.45 fourth quarter —
      Seniors Housing Fund I total equity commitments $2.5B the fourth quarter —
      Seniors Housing Operating portfolio properties 1,659 4Q25 —
      Seniors Housing Operating portfolio units 160,218 4Q25 —
      Seniors Housing Operating Same Store properties 875 4Q25 —
      SHO average occupancy growth 400 the fourth quarter —
      SHO portfolio same store NOI growth 20.4% the fourth quarter —
      SHO Revenue Per Occupied Room (RevPOR) growth 4.7% the fourth quarter —
      SHO SSNOI margin expansion 270 the fourth quarter —
      Total capital sourced $23B full year 2025 —
      Total dispositions completed for full year $8.2B full year 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      WELL
      Welltower Inc.
      this stock
      		$166.20B +26.8% +35.6% 117.1 2.5%
      VTR
      Ventas, Inc.
      		 $46.78B +17.9% +18.5% 168.9 4.6%
      DOC
      Healthpeak Properties, Inc.
      		 $14.24B +29.1% +4.5% 59.0 3.5%
      OHI
      Omega Healthcare Investors Inc
      		 $14.11B +4.7% +13.2% 16.6 4.2%
      AHR
      American Healthcare REIT, Inc.
      		 $11.86B +15.6% +9.1% 78.9 10.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      1,588
      % held
      101.1%
      Net QoQ
      +37.3M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      1,001
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      17.7M
      Days to cover
      5.9d
      Change
      -1.4M sh
      View
      Short Volume
      Short vol %
      55%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.4K
      Value
      $602.7K
      As of
      Jul 28, 2026
      View
      Off-Exchange
      Off-exchange %
      40.8%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      Alan Armstrong
      Amount
      $1.0K–$15.0K
      Traded
      Mar 30, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $10.8B
      Net income (FY)
      $936.8M
      EPS diluted
      $1.39
      View
      Buybacks
      Authorized
      $3.0B
      Remaining
      $3.0B
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 28, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $605.4K
      Shares
      4.0K
      Filed
      Apr 30, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 28, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      WELL +4.2% -4.4% +13.1% +0.4% +26.9%
      SPY -0.4% +2.6% +10.7% +2.7% +12.5%
      vs SPY +4.6% -7.0% +2.3% -2.3% +14.3%

      Capital returns

      Latest dividend
      $0.85 / share · ex Aug 12, 2026
      Raised 14.9%
      Paid (TTM)
      $3.07 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.30%
      Buyback program · as of Jun 30, 2026
      Authorized
      $3.00B
      Spent (derived)
      $0
      Remaining
      $3.00B
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 766704 CUSIP 95040Q104 13F (30d) 1396 filings 1330 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)